Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Shortlist Revealed Ahead Of October Awards

10th Global Generics & Biosimilars Awards Will Be Presented In Barcelona On 25 October 2023

Executive Summary

Ahead of the Global Generics & Biosimilars Awards, which are this year being held on Wednesday 25 October at the Hotel Porta Fira in Barcelona, we reveal our final shortlist of entrants across all 14 categories.

As the Global Generics & Biosimilars Awards 2023 draws closer, the final shortlist of entrants for this year’s ceremony has now been revealed, with some of the industry’s biggest names competing across all 14 of our categories to be recognized for their achievements.

Our panel of judges has now completed evaluating all entries received this year – a record year for the awards, in which more than 100 entries were received in total, from almost 50 companies (see sidebar) – and these scores have been used to compile the final shortlist ahead of our prizegiving ceremony on Wednesday 25 October.

Full details of the shortlisted nominees are available here.

The ceremony, which is free to attend, will take place at the Hotel Porta Fira in Barcelona and will recognize nominees for activities that took place between 1 August 2022 and 31 August 2023. (Also see "GGB Awards Returns To Barcelona In Its 10th Year" - Generics Bulletin, 23 Feb, 2023.)

In 2023 – the tenth year of the GGB Awards – the event is once again backed by our headline sponsor, IQVIA – along with category sponsors Adalvo, Aurobindo, Pharmacloud, Pharmawise and West Pharmaceutical Services – and us also supported by International Health Partners, the International Generic and Biosimilar Medicines Association, and the US Association for Accessible Medicines and its Biosimilars Council. Meanwhile, Sandoz will be the sponsor of our welcome reception.

Across our categories, the Global Generics & Biosimilars Awards covers an array of industry activities. This year, we have introduced a new category recognizing promotional campaigns in addition to our 13 other regular categories.

Alongside the global and regional Company of the Year awards – recognizing the world leader as well as top companies in the EMEA, Americas and Asia-Pacific regions – our categories also include Business Development of the Year, Acquisition of the Year and Industry Partner of the Year, while other specific categories also cover Biosimilars and Value Added Medicines.

Outstanding achievements in company leadership and corporate social responsibility are also honored during the ceremony.

Generics Bulletin’s editors recently discussed details of the event in a podcast, including a breakdown of our 14 categories. (Also see "Podcast: The Global Generics & Biosimilars Awards 2023" - Generics Bulletin, 27 Jun, 2023.)

For full details of the awards, including our categories, sponsors and how to register to attend, click here.

To enquire about sponsorship opportunities for the Global Generics & Biosimilars Awards 2023, please e-mail [email protected]

And to register interest in attending the Global Generics & Biosimilars Awards 2023, to receive the latest updates and for any further details, please e-mail [email protected]

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts